Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Nature|September 22, 2006
Gene therapy: is IL2RG oncogenic in T-cell development?Karin Pike-Overzet, Dick de Ridder, Floor Weerkamp, et al.
Leukemia|February 3, 2007
Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapyK Pike-Overzet, D de Ridder, F Weerkamp, et al.
The Journal of Experimental Medicine|June 2, 2005
New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profilingWillem A Dik, Karin Pike-Overzet, Floor Weerkamp, et al.
Leukemia|July 2, 2003
DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markersF J T Staal, M van der Burg, L F A Wessels, et al.
British Journal of Cancer|June 27, 2002
A novel germline mutation of PTEN associated with brain tumours of multiple lineagesF J T Staal, R B van der Luijt, M R M Baert, et al.
Leukemia|May 28, 2011
Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transferK Pike-Overzet, M Rodijk, Y-Y Ng, et al.
Immunity|August 20, 2013
Canonical Wnt signaling negatively modulates regulatory T cell functionJorg van Loosdregt, Veerle Fleskens, Machteld M Tiemessen, et al.
NPJ Vaccines|March 20, 2021
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory diseaseJoan E M van der Lubbe, Sietske K Rosendahl Huber, Aneesh Vijayan, et al.
The Journal of Experimental Medicine|April 28, 2021
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHPLaura Solforosi, Harmjan Kuipers, Mandy Jongeneelen, et al.
Pageof 7